These immune complexes activate platelets via FcγRIIa binding, resulting in thrombocytopenia and platelet activation (see Pathogenesis of thrombosis and thrombocytopenia in anti‐PF4 disorders). This evidence concerns the gene PF4 and Venous thrombosis.